Vitamin Shoppe First Quarter Earnings Sneak Peek

Vitamin Shoppe (NYSE:VSI) will unveil its latest earnings on Tuesday, May 8, 2012. Vitamin Shoppe is a retailer and direct marketer of vitamins, minerals, herbs, supplements, sports nutrition and other health and wellness products.

Vitamin Shoppe Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 57 cents per share, a rise of 16.3% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from 56 cents. Between one and three months ago, the average estimate moved up. It has been unchanged at 57 cents during the last month. Analysts are projecting profit to rise by 12% versus last year to $1.86.

Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 6 cents, reporting profit of 38 cents per share against a mean estimate of net income of 32 cents per share.

Investing Insights: What’s the Future of Microsoft’s Stock?

Wall St. Revenue Expectations: Analysts predict a rise of 10.5% in revenue from the year-earlier quarter to $239.7 million.

Analyst Ratings: Analysts are optimistic about this stock, with eight analysts rating it as a buy, none rating it as a sell and five rating it as a hold.

A Look Back: In the fourth quarter of the last fiscal year, profit rose 57.9% to $9.4 million (32 cents a share) from $6 million (20 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 19.2% to $214.9 million from $180.3 million.

Key Stats:

The company enters this earnings announcement with substantial revenue momentum. The company has averaged year-over-year revenue growth of 14.1% over the last four quarters.

After experiencing income increases the last three quarters, the company is hoping to keep the good news coming with this earnings announcement. Net income rose 63.5% in the second quarter of the last fiscal year and 64.3% in the third quarter of the last fiscal year before increasing again in the fourth quarter of the last fiscal year.

Stock Price Performance: Between March 6, 2012 and May 2, 2012, the stock price had risen $4.18 (9.7%), from $43.07 to $47.25. The stock price saw one of its best stretches over the last year between September 9, 2011 and September 19, 2011, when shares rose for seven straight days, increasing 7% (+$2.80) over that span. It saw one of its worst periods between December 9, 2011 and December 15, 2011 when shares fell for five straight days, dropping 7.8% (-$3) over that span.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Don’t Miss These Additional Hot Stories:

Why Are These Health Stocks Feeling Under the Weather?

What Do Americans Think About Gold?>>

Here’s How to Bet on a Baby Boom>>